Access

Letter

Nature 453, 672-676 (29 May 2008) | doi:10.1038/nature07013; Received 29 February 2008; Accepted 18 April 2008; Published online 21 May 2008

Open Innovation Challenges

naturejobs

CLEC5A is critical for dengue-virus-induced lethal disease

Szu-Ting Chen1, Yi-Ling Lin2,3, Ming-Ting Huang1, Ming-Fang Wu1, Shih-Chin Cheng1, Huan-Yao Lei4, Chien-Kuo Lee5, Tzyy-Wen Chiou6, Chi-Huey Wong3 & Shie-Liang Hsieh1,3,7

  1. Department and Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan
  2. Institute of Biomedical Sciences, and,
  3. Genomics Research Center, Academia Sinica, Taipei 115, Taiwan
  4. Department of Microbiology and Immunology, National Cheng Kung University, Tainan 701, Taiwan
  5. Institute of Immunology, National Taiwan University, Taipei 100, Taiwan
  6. Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974, Taiwan
  7. Immunology Research Center, National Yang-Ming University & Taipei Veterans General Hospital, Taipei 112, Taiwan

Correspondence to: Shie-Liang Hsieh1,3,7 Correspondence and requests for materials should be addressed to S-L H. (Email: slhsieh@ym.edu.tw or Email: slhsieh@gate.sinica.edu.tw).

Top

Dengue haemorrhagic fever and dengue shock syndrome, the most severe responses to dengue virus (DV) infection, are characterized by plasma leakage (due to increased vascular permeability) and low platelet counts1, 2. CLEC5A (C-type lectin domain family 5, member A; also known as myeloid DAP12-associating lectin (MDL-1))3 contains a C-type lectin-like fold similar to the natural-killer T-cell C-type lectin domains and associates with a 12-kDa DNAX-activating protein (DAP12)4 on myeloid cells. Here we show that CLEC5A interacts with the dengue virion directly and thereby brings about DAP12 phosphorylation. The CLEC5A–DV interaction does not result in viral entry but stimulates the release of proinflammatory cytokines. Blockade of CLEC5A–DV interaction suppresses the secretion of proinflammatory cytokines without affecting the release of interferon-alpha, supporting the notion that CLEC5A acts as a signalling receptor for proinflammatory cytokine release. Moreover, anti-CLEC5A monoclonal antibodies inhibit DV-induced plasma leakage, as well as subcutaneous and vital-organ haemorrhaging, and reduce the mortality of DV infection by about 50% in STAT1-deficient mice. Our observation that blockade of CLEC5A-mediated signalling attenuates the production of proinflammatory cytokines by macrophages infected with DV (either alone or complexed with an enhancing antibody) offers a promising strategy for alleviating tissue damage and increasing the survival of patients suffering from dengue haemorrhagic fever and dengue shock syndrome, and possibly even other virus-induced inflammatory diseases.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Dengue virus and dendritic cells

Nature Medicine News and Views (01 Jul 2000)